NextCure (NXTC) Other Non Operating Income (2018 - 2026)
NextCure (NXTC) posted quarterly Other Non Operating Income of $309000.0 for Q1 2026, down 52.17% year-over-year from $646000.0 in Q1 2025, and down 3.74% quarter-over-quarter from $321000.0 in Q4 2025.
NextCure (NXTC) Other Non Operating Income (2018 - 2026) Analysis & Trends
NextCure's Other Non Operating Income history runs 9 years deep, the most recent figure standing at $309000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 52.17% year-over-year to $309000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 59.5% YoY), while the FY2025 annual figure was $1.8 million, down 56.72% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $309000.0, down from $321000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.3 million in Q4 2023, with the low at $169000.0 in Q1 2022.
- The 5-year median for Other Non Operating Income is $646000.0 (2025), against an average of $721470.6.
- Peak annual rise in Other Non Operating Income reached 694.29% in 2022, while the deepest fall reached 75.89% in 2022.
- NextCure's Other Non Operating Income stood at $471000.0 in 2022, then jumped by 180.89% to $1.3 million in 2023, then sank by 35.6% to $852000.0 in 2024, then tumbled by 62.32% to $321000.0 in 2025, then fell by 3.74% to $309000.0 in 2026.
- Business Quant data shows NXTC's Other Non Operating Income at $309000.0 in Q1 2026, $321000.0 in Q4 2025, and $321000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 202,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 321,000.00 |
| Sep 30, 2025 | 321,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | 646,000.00 |
| Dec 31, 2024 | 852,000.00 |
| Sep 30, 2024 | 955,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 975,000.00 |
| Dec 31, 2022 | 471,000.00 |
| Sep 30, 2022 | 328,000.00 |
| Jun 30, 2022 | 208,000.00 |
| Mar 31, 2022 | 169,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Sep 30, 2021 | 578,000.00 |